MarketScreener Homepage > News > Sectors > Healthcare

News : Sectors

PING AN HEALTHCARE AND TECHNOL.

SoftBank Vision Fund's climbing, sliding valuations

HENRY SCHEIN, INC.

Drug firms offer to settle U.S. opioid suits with $50 billion package: sources

AURORA CANNABIS INC.

TSX rises 0.05% to 16,427.18

05:05a	SNAKES AND LADDERS : SoftBank Vision Fund's climbing, sliding valuations	RE
10/14	J&J'S JANSSEN : FDA OK's Xarelto in Acutely Ill Medical Patients	DJ
10/14	ABBOTT LABORATORIES : Labs Partners with Omada Health on Type 2 Diabetes Care	DJ
10/14	ALLERGAN : Form 8.3 - Allergan Plc	DJ
10/14	Johnson & Johnson's Legal Challenges Mount	DJ
10/11	SoftBank-backed Vir Biotechnology's shares tumble in market debut	RE
10/11	ELI LILLY AND : FDA Approves Eli Lilly's Reyvow for Migraine Patients	DJ
10/11	The revival in interest should continue
10/11	ALLERGAN : Form 8.3 - Allergan Plc	DJ
10/10	ZIMMER BIOMET : Former Executive Wasn't Defamed When Biomet Called Him a Compliance Risk, Court Rules	DJ
10/10	GILEAD SCIENCES : Galapagos See Efficacy in Advanced Rheumatoid Arthritis Study	DJ
10/10	Reata Pharmaceuticals Shares Up 8% on Re-Acquiring Bardoxolone Rights	DJ
10/10	Stealth BioTherapeutics Up 14%; In Agreement With Alexion	DJ
10/10	Pot producer Hexo withdraws 2020 forecast, shares slump	RE
10/10	Germany's Merck KGaA Acquires FloDesign Sonics	DJ

The best opportunities.
All the markets. Each month. In one click.

Discover

09:14a	JOHNSON & JOHNSON : J&J Recalls One Baby Powder Lot After Test Shows Subordinated-Trace Asbestos Levels	DJ
08:08a	ABBVIE : Gets CHMP Positive Opinion for Rinvoq in Rheumatoid Arthritis	DJ
07:56a	JOHNSON & JOHNSON : J&J's Janssen Gets CHMP Positive Option for Spravato	DJ
07:36a	JOHNSON & JOHNSON : Genmab, Janssen Get CHMP Positive Option for Expanded Darzalex Use	DJ
07:36a	MERCK AND : Gets Positive EU CHMP Opinion for Two New Regimens of Keytruda	DJ
07:23a	MERCK AND : Gets CHMP Positive Opinion for V920 Ebola Zaire Virus Vaccine	DJ
06:50a	AMGEN : UCB Get CHMP Positive Opinion for Evenity	DJ
10/17	JOHNSON & JOHNSON : Janssen Presents New Long-term Tremfya Data	DJ
10/17	INTUITIVE SURGICAL : Beats Wall Street 3Q Targets	DJ
10/17	JOHNSON & JOHNSON : to Pay $117 Million Over Surgical Device Marketing	DJ
10/17	TEVA PHARMACEUTICAL INDUSTRIES : UK arm recalls some batches of Ranitidine - Medicines watchdog	RE
10/17	ALLERGAN : Form 8.3 -	DJ
10/17	Teva to donate over $15 billion worth of drugs in opioid settlement - source	RE
10/17	JOHNSON & JOHNSON : J&J Seeks $4 Billion Opioid Settlement	DJ
10/16	DRUG FIRMS OFFER TO SETTLE U.S. OPIOID SUITS WITH $50 BILLION PACKAGE : sources	RE
10/16	TSX rises 0.05% to 16,427.18	RE
10/16	PREMIER : GE Healthcare, Premier Inc. Team on One-Stop Breast Cancer Center Model	DJ
10/16	JOHNSON & JOHNSON : J&J Offers $4 Billion Opioid Litigation Settlement	DJ
10/16	Johnson & Johnson Shares Rise	DJ
10/16	ALLERGAN : Form 8.3 -	DJ
10/16	Attractive timing with a long term view to go long again
10/16	ABBOTT LABORATORIES : Tweaks 2019 Profit Outlook	DJ
10/16	ACHILLION PHARMACEUTICALS : Shares Up 84% on Buyout Deal	DJ
10/16	ABBOTT LABORATORIES : 3Q Sales Slightly Lower Than Wall Street Targets	DJ
10/16	INCYTE : Says Phase 3 REACH2 Trial Meets Endpoint	DJ
10/16	ELI LILLY AND : Phase 3 Pegilodecakin Study Misses Main Endpoint in Pancreatic Cancer	DJ
10/16	ALEXION PHARMACEUTICALS : Buys Achillion Pharma for $930 Million	DJ
10/16	UNITEDHEALTH : Lifts Outlook as Sales Rise	DJ
10/16	ROCHE : Says Outlook Is Improving as Revenue Grows	DJ
10/15	TSX rises 0.02 percent to 16,418.39	RE
10/15	New Gilead Sciences CFO Expected to Pursue More Deals to Expand Portfolio	DJ
10/15	JOHNSON & JOHNSON : Raises Outlook, Beats Profit Estimates -- 2nd Update	DJ
10/15	UNITEDHEALTH : Raises Profit Targets on Higher Sales -- Update	DJ
10/15	ELI LILLY AND : Correction to Eli Lilly Promoting Women Article on Oct. 15 -- Journal Report	DJ
10/15	Insurers Rise With UnitedHealth Earnings Beat	DJ
10/15	MERCK : Progyny Inc. Sets IPO at 10 Million Shares; Sees Pricing at $14-$16 Each	DJ
10/15	JOHNSON & JOHNSON : Raises Outlook, Beats Profit Estimates -- Update	DJ
10/15	UnitedHealth Group on Pace for Largest Percent Increase Since October 2016 -- Data Talk	DJ
10/15	TANDEM DIABETES CARE : Up 10%; To Work With Abbott	DJ
10/15	UNITEDHEALTH : Shares Rise on Earnings Beat	DJ
10/15	HUMANA : DeSalvo Resigns From Humana Board	DJ
10/15	CROSSJECT : Cooperation agreement with the US Department of Defense	AL
10/15	ALLERGAN : Form 8.3 - Allergan Plc	DJ
10/15	GILEAD SCIENCES : Names Andrew Dickinson Chief Financial Officer	DJ
10/15	JOHNSON & JOHNSON : Raises Outlook, Beats Profit Estimates	DJ
10/15	UNITEDHEALTH : Raises Profit Targets on Higher Sales	DJ
10/15	J&J's Courtroom Losses Pile Up -- WSJ	DJ
10/15	ELI LILLY AND : Inside Eli Lilly's Successful Strategy to Promote More Women -- Journal Report	DJ
10/14	MERCK : Drugmaker to Test Machine Learning to Prevent Drug Shortages	DJ
10/14	UnitedHealth Likely to Record Higher Sales -- Earnings Preview	DJ

The best opportunities.
All the markets. Each month. In one click.

Discover

05:06p	JOHNSON & JOHNSON : J&J Recalls Baby Powder on Asbestos Concern -- 2nd Update	DJ
02:02p	Johnson & Johnson Down Over 5%, on Pace for Largest Percent Decrease Since December 2018 -- Data Talk	DJ
02:00p	J&J Recalls Baby Powder on Asbestos Concern -- Update	DJ
11:30a	SANOFI : Recalls Over-the-Counter Zantac in U.S. and Canada	DJ
10:17a	ALLERGAN : Form 8.3 -	DJ

1 2 3 4 5 6 7 8 9 10 Next

MOST READ NEWS

1	IMERYS : IMERYS : FDA alerts consumers of J&J baby powder recall, says it stands by tests
2	FACEBOOK : FACEBOOK : G20 kicks off debate to regulate 'stablecoins' in hit to Facebook's Libra
3	OpenText statement regarding Micro Focus International plc ("Micro Focus")
4	ROSEN, A LEADING LAW FIRM, Reminds Dropbox, Inc. Investors of Important December 3rd Deadline in Securities..
5	NEWS CORPORATION : NEWS : to supply headlines for Facebook's upcoming news tab